Jean Luc Sarrazin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jean Luc Sarrazin has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anaïs Venard
Department of Neurosurgery, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France
1 shared publication - Anne Herbrecht
Department of Neurosurgery, Bicêtre Hospital, Le Kremlin-Bicêtre, France
1 shared publication - Antoine Hakime
Gustave Roussy Institute, 39 r Camille Desmoulins, 94805, Villejuif, France,
1 shared publication - Benjamin Moulin
From the Interventional Radiology Unit, Imaging Department (B.M., G.A., J.L.S., O.V., M.D.P., A.H.), From the Orthopedic Surgery Unit (S.R), and From the Anesthesiology Department (TG), American Hospital of Paris, Neuilly-sur-Seine, France
1 shared publication - Fabrice Parker
Department of Neurosurgery, Bicêtre Hospital, AP-HP, 94270 Le Kremlin-Bicêtre, France
1 shared publication - Farida Benoudiba
Department of neuroradiology, Bicêtre Hospital, Le Kremlin-Bicêtre, France
1 shared publication
Latest Publications
- 29 October 2025
- Published by Springer Nature in European Spine Journal
- Vol. 35 (6) , 3258-3266
An integrated classification to guide the management of spinal meninges pathologies
Purpose The terminology used for spinal meningeal pathologies is often inconsistent, with multiple terms referring to similar or related anatomical anomalies. This lack of standardization leads to variability in the management of these lesions, with differing diagnostic and therapeutic approaches for similar conditions. Our aim was to revise the classification of spinal meningeal pathologies by integrating pathogenesis, diagnostic criteria, and therapeutic strategies. Methods We first conducted a descriptive cohort study over a ten-year period at a single neurosurgical reference center. Clinical and radiological data were collected, and spinal meningeal pathologies were categorized according to a revised classification system. Next, we administered an online survey featuring selected cases to spine surgeons and neuroradiologists, comparing their responses to our proposed classification. Results A total of 264 patients with 273 lesions were included. The lesions were categorized into dural pathologies (n = 192), comprising diverticula (n = 129), dissections (n = 46), and ectasia (n = 17); and arachnoid pathologies (n = 81), including cysts (n = 20), webs (n = 32), and arachnoiditis (n = 29). For each diagnosis, we identified specific clinical and radiological features and selected illustrative cases. A total of 93 physicians participated in the online survey (51.7% spine surgeons). We found that conventional diagnostic terms were still widely used and that misdiagnoses were common, even between duropathies and arachnoidopathies. Conclusions We propose an integrated classification of spinal meningeal pathologies to standardize terminology and guide management. This framework can be adopted by spine surgeons, radiologists, and neurologists to ensure a more consistent approach to diagnosing and treating these conditions.
- 29 October 2025
- Published by Springer Nature in European Spine Journal
- Vol. 35 (6) , 3258-3266
An integrated classification to guide the management of spinal meninges pathologies
Purpose The terminology used for spinal meningeal pathologies is often inconsistent, with multiple terms referring to similar or related anatomical anomalies. This lack of standardization leads to variability in the management of these lesions, with differing diagnostic and therapeutic approaches for similar conditions. Our aim was to revise the classification of spinal meningeal pathologies by integrating pathogenesis, diagnostic criteria, and therapeutic strategies. Methods We first conducted a descriptive cohort study over a ten-year period at a single neurosurgical reference center. Clinical and radiological data were collected, and spinal meningeal pathologies were categorized according to a revised classification system. Next, we administered an online survey featuring selected cases to spine surgeons and neuroradiologists, comparing their responses to our proposed classification. Results A total of 264 patients with 273 lesions were included. The lesions were categorized into dural pathologies (n = 192), comprising diverticula (n = 129), dissections (n = 46), and ectasia (n = 17); and arachnoid pathologies (n = 81), including cysts (n = 20), webs (n = 32), and arachnoiditis (n = 29). For each diagnosis, we identified specific clinical and radiological features and selected illustrative cases. A total of 93 physicians participated in the online survey (51.7% spine surgeons). We found that conventional diagnostic terms were still widely used and that misdiagnoses were common, even between duropathies and arachnoidopathies. Conclusions We propose an integrated classification of spinal meningeal pathologies to standardize terminology and guide management. This framework can be adopted by spine surgeons, radiologists, and neurologists to ensure a more consistent approach to diagnosing and treating these conditions.
- Open Access
- 29 December 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (1) , 87
Prostate Artery Embolization: Challenges, Tips, Tricks, and Perspectives
Prostatic artery embolization (PAE) consists of blocking the arteries supplying the prostate to treat benign prostate hypertrophia (BPH). Its effectiveness on both urinary symptoms and flowmetric parameters has now been amply demonstrated by around a hundred studies, including several randomized trials. The main advantage of this procedure is the very low rate of urinary and sexual sequelae, including ejaculatory, with an excellent tolerance profile. The arterial anatomy is a key element for the realization of PAE. Its knowledge makes it possible to anticipate obstacles and prevent potential complications related to nontarget embolization. Nontarget embolization can occur with a small intraprostatic shunt or reflux and has no consequences except some local inflammation symptoms that resolve in a couple of days. Nevertheless, some situations with large arterial shunts arising from the prostatic artery must be recognized (accessory rectal, bladder, or pudendal branches), and must imperatively be protected before embolization, at the risk of exposing oneself to otherwise ischemic complications that are more severe, such as bladder necrosis and skin or mucosal necrosis. This article offers a step-by-step review of the various anatomical and technical key points to ensure technical and clinical success, while avoiding the occurrence of adverse events.
- 29 December 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (1) , 87
Open AccessProstate Artery Embolization: Challenges, Tips, Tricks, and Perspectives
Prostatic artery embolization (PAE) consists of blocking the arteries supplying the prostate to treat benign prostate hypertrophia (BPH). Its effectiveness on both urinary symptoms and flowmetric parameters has now been amply demonstrated by around a hundred studies, including several randomized trials. The main advantage of this procedure is the very low rate of urinary and sexual sequelae, including ejaculatory, with an excellent tolerance profile. The arterial anatomy is a key element for the realization of PAE. Its knowledge makes it possible to anticipate obstacles and prevent potential complications related to nontarget embolization. Nontarget embolization can occur with a small intraprostatic shunt or reflux and has no consequences except some local inflammation symptoms that resolve in a couple of days. Nevertheless, some situations with large arterial shunts arising from the prostatic artery must be recognized (accessory rectal, bladder, or pudendal branches), and must imperatively be protected before embolization, at the risk of exposing oneself to otherwise ischemic complications that are more severe, such as bladder necrosis and skin or mucosal necrosis. This article offers a step-by-step review of the various anatomical and technical key points to ensure technical and clinical success, while avoiding the occurrence of adverse events.